| Original language | English (US) |
|---|---|
| Pages (from-to) | e29 |
| Journal | The Lancet Respiratory Medicine |
| Volume | 5 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2017 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Cite this
Hurst, J. R., Anzueto, A. R., & Vestbo, J. (2017). Susceptibility to exacerbation in COPD. The Lancet Respiratory Medicine, 5(9), e29. https://doi.org/10.1016/S2213-2600(17)30307-7
Susceptibility to exacerbation in COPD. / Hurst, John R.; Anzueto, Antonio R; Vestbo, Jørgen.
In: The Lancet Respiratory Medicine, Vol. 5, No. 9, 01.09.2017, p. e29.Research output: Contribution to journal › Letter
Hurst, JR, Anzueto, AR & Vestbo, J 2017, 'Susceptibility to exacerbation in COPD', The Lancet Respiratory Medicine, vol. 5, no. 9, pp. e29. https://doi.org/10.1016/S2213-2600(17)30307-7
Hurst JR, Anzueto AR, Vestbo J. Susceptibility to exacerbation in COPD. The Lancet Respiratory Medicine. 2017 Sep 1;5(9):e29. https://doi.org/10.1016/S2213-2600(17)30307-7
@article{e0667a304df547bdacf92c421e991ee4,
title = "Susceptibility to exacerbation in COPD",
author = "Hurst, {John R.} and Anzueto, {Antonio R} and J{\o}rgen Vestbo",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/S2213-2600(17)30307-7",
language = "English (US)",
volume = "5",
pages = "e29",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Limited",
number = "9",
}
TY - JOUR
T1 - Susceptibility to exacerbation in COPD
AU - Hurst, John R.
AU - Anzueto, Antonio R
AU - Vestbo, Jørgen
PY - 2017/9/1
Y1 - 2017/9/1
UR - http://www.scopus.com/inward/record.url?scp=85028440186&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028440186&partnerID=8YFLogxK
U2 - 10.1016/S2213-2600(17)30307-7
DO - 10.1016/S2213-2600(17)30307-7
M3 - Letter
C2 - 28853400
AN - SCOPUS:85028440186
VL - 5
SP - e29
JO - The Lancet Respiratory Medicine
JF - The Lancet Respiratory Medicine
SN - 2213-2600
IS - 9
ER -